Lessons Learned from Santa Barbara


Author: Stephen Barlas

The key instigators of one of the most prominent health-IT demonstrations in the past decade came to Washington on August 1 to issue an unusual mea culpa for the Santa Barbara Care Data Exchange, which flamed out in December 2006. The soul-bearing by participants, including recently departed U.S. health-IT czar David Brailer, who was primarily responsible for originating the demonstration in 1999 while he was CEO of a health-IT company called CareScience, was timed to coincide with the appearance of a series of articles on the Web site of Health Affairs magazine, which sponsored the briefing.

Brailer, Sam Karp, vice president at the California HealthCare Foundation (CHCF), which provided $10 million for the Santa Barbara experiment, and Robert Miller, a University of California professor, addressed the failures of the project which was once a shining star, but which ultimately crashed and burned. “Many thought the Santa Barbara project had been successful,” explained Miller, “which is why a lot of people were surprised when it was closed down with very little data exchange having occurred.”

Among the project’s key failures was the absence of any community leadership, which was passive in the face of the CHCF doing all the heavy lifting financially, mishandling of the software needs, particularly the complexities of developing data interfaces and the failure to develop and sell a value proposition relating to the use of health information at the point of care. “The business model was out of line with the value proposition,” Brailer said. Physicians and hospitals viewed the project as costing them money and losing revenue, he added.

He explained that he believes the business model will triumph over the value model. “But I don’t know how long that will take,” he states.

Brailer argued that he was well aware of the project’s failings in 2004 when President Bush appointed him as National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services. Brailer said that he applied what he’d learned so far in that job, although none of the three speakers addressed the important question of whether the health-IT infrastructure nationally benefited from Brailer’s propounding of the Santa Barbara lessons during his four year tenure.

Certainly the continuing effort by the HHS to speed up development of a national network has borne not much more than mixed results. With regard to software development, Karp criticized the federal effort here, which has been centered around the American Health Information Community, an advisory group to the HHS, which is now being transitioned into a private sector group. “National data standard development has been too slow, too cumbersome, and politically dominated by large vendors, and that has   to change,” said Karp.

Moreover, Karp cited a report released on July 26 by the Commonwealth Fund which evaluated the major congressional bills aimed at speeding health-IT implementation. The report said the “provisions may be insufficient to promote the adoption of information technology.”

Want to read more expert articles like this? Subscribe to Digital HealthCare & Productivity.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.